Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Publisher Name :
Date: 30-Mar-2022
No. of pages: 96
Inquire Before Buying

The global RNAi therapeutics market is expected to record a value of US$1.15 billion in 2026, progressing at a CAGR of 10.19%, over the period 2022-2026. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress in collaborations and associated deals in RNAi therapeutics. However, the market growth would be challenged by complexity associated with the drug delivery of RNAi therapeutics, high development cost of RNA interference-based therapeutics and stringent regulatory requirements. A few notable trends include growing popularity of personalized medicine, surging preference RNAi therapeutics as an alternative for HTS & keloids treatment and escalating applications in molecular diagnostics.

The global market has been segmented on the basis of molecule type, application and end-user. On the basis of molecule type, the global market can be bifurcated into small interfering RNAs (siRNAs) and microRNAs (miRNAs). According to applications, the market can be divided into oncology, respiratory disorders, neurological disorders, liver disorders, autoimmune disorders and other disorders. Whereas, the global RNAi therapeutics market is split into research & academic laboratories and hospitals & diagnostic laboratories, in terms of end-user.

The fastest growing regional market is North America owing to increasing prevalence of chronic conditions, rising investments for development of RNAi therapeutics along with growing number of research activities for RNA-based therapeutics in the region. Further, the COVID-19 pandemic has positively impacted the market due to the growing relevance of RNA-based investigations as well as increasing funding for R&D activities.

Scope of the report:


  • The report provides a comprehensive analysis of the global RNAi therapeutics market segmented on the basis of molecule type, application, end-user and region, with potential impact of COVID-19.

  • The major regional and country markets (North America, Europe, Asia Pacific and RoW) have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Sanofi S.A., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Benitec Biopharma Ltd., and Sirnaomics, Ltd.) are also presented in detail.


Key Target Audience:


  • RNAi Therapeutics Service/Equipment Providers and Distributors

  • Pharmaceutical, Biopharmaceutical & Biotechnological Companies

  • Research and Development (R&D) Organizations

  • End Users

  • Government Bodies & Regulating Authorities

Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

Table of Contents

1. Market Overview
1.1 Introduction
1.2 Different Classes of RNA Therapeutics
1.3 Major Pathways of RNAi
1.4 Various Small RNA Isoforms related to RNAi
1.5 Key Features of RNAi Therapeutics
1.6 Comparison of RNAi Treatments against Other Treatment Classes
1.7 Platform Comparison of RNAi Therapeutics
1.8 Applications of RNAi in Vivo

2. Impact of COVID-19
2.1 Rapid Spread of Coronavirus
2.2 Growth in COVID-19 R&D Funding
2.3 RNA Vaccine Development for COVID-19

3. Global Market Analysis
3.1 Global RNAi Therapeutics Market by Value
3.2 Global RNAi Therapeutics Market Forecast by Value
3.3 Global RNAi Therapeutics Market by Molecule Type
3.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market by Value
3.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value
3.3.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Type
3.3.4 Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value
3.3.5 Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value
3.3.6 Global MicroRNA (miRNA) Therapeutics Market by Value
3.3.7 Global MicroRNA (miRNA) Therapeutics Market Forecast by Value
3.4 Global RNAi Therapeutics Market by Application
3.4.1 Global RNAi Therapeutics Application Market by Value
3.4.2 Global RNAi Therapeutics Product Market Forecast by Value
3.5 Global RNAi Therapeutics Market by End-Users
3.5.1 Global RNAi Therapeutics End-User Market by Value
3.5.2 Global RNAi Therapeutics End-User Market Forecast by Value
3.6 Global RNAi Therapeutics Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America RNAi Therapeutics Market by Value
4.1.2 North America RNAi Therapeutics Market Forecast by Value
4.1.3 The U.S. RNAi Therapeutics Market Forecast by Value
4.2 Europe
4.2.1 Europe RNAi Therapeutics Market by Value
4.2.2 Europe RNAi Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific RNAi Therapeutics Market by Value
4.3.2 Asia Pacific RNAi Therapeutics Market Forecast by Value
4.4 RoW
4.4.1 RoW RNAi Therapeutics Market by Value
4.4.2 RoW RNAi Therapeutics Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Utilization in Oncology Pharmaceuticals
5.1.2 Accelerating Growth Rates of Infectious Diseases
5.1.3 Enlarging Geriatric Population
5.1.4 Increasing Prevalence of Neurodegenerative Disorders
5.1.5 Progress in Collaborations & Associated Deals in RNAi Therapeutics
5.1.6 Expanding Research & Development Activities
5.2 Key Trends and Developments
5.2.1 Growing Popularity of Personalized Medicine
5.2.2 Surging Preference as an Alternative for HTS & Keloids Treatment
5.2.3 Escalating Applications in Molecular Diagnostics
5.2.4 Development of RNAi Therapeutics
5.3 Challenges
5.3.1 Complexity Associated with the Delivery of RNAi Therapeutics
5.3.2 High Development Cost of RNA Interference-Based Therapeutics
5.3.3 Stringent Regulatory Requirements

6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players

7. Company Profiles
7.1 Sanofi S.A. (Genzyme Corporation)
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Alnylam Pharmaceuticals Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Arrowhead Pharmaceuticals Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Arbutus Biopharma Corporation
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Benitec Biopharma Ltd.
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Sirnaomics, Ltd.
7.6.1 Business Overview
7.6.2 Business Strategies

List of Figures

Schematic Illustration of Different Classes of RNA Therapeutics
RNA Interference Therapeutic Process
Various Small RNA Isoforms related to RNAi
Key Features of RNAi Therapeutics
Applications of RNAi in Vivo
Number of Cumulative Cases of Coronavirus (COVID-19) Worldwide (2020)
COVID-19 R&D Funding by Major Countries (2020)
mRNA Vaccine in Development for COVID-19
Global RNAi Therapeutics Market by Value (2017-2021)
Global RNAi Therapeutics Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Molecule Type (2021)
Global Small Interfering RNA (siRNA) Therapeutics Market by Value (2017-2021)
Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Value (2022-2026)
Global Small Interfering RNA (siRNA) Therapeutics Market by Type (2021)
Global Small Interfering RNA (siRNA) Therapeutics Type Market by Value (2017-2021)
Global Small Interfering RNA (siRNA) Therapeutics Type Market Forecast by Value (2022-2026)
Global MicroRNA (miRNA) Therapeutics Market by Value (2017-2021)
Global MicroRNA (miRNA) Therapeutics Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Application (2021)
Global RNAi Therapeutics Application Market by Value (2017-2021)
Global RNAi Therapeutics Product Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by End-Users (2021)
Global RNAi Therapeutics End-User Market by Value (2017-2021)
Global RNAi Therapeutics End-User Market Forecast by Value (2022-2026)
Global RNAi Therapeutics Market by Region (2021)
North America RNAi Therapeutics Market by Value (2017-2021)
North America RNAi Therapeutics Market Forecast by Value (2022-2026)
The U.S. RNAi Therapeutics Market Forecast by Value (2020-2026)
Europe RNAi Therapeutics Market by Value (2017-2021)
Europe RNAi Therapeutics Market Forecast by Value (2022-2026)
Asia Pacific RNAi Therapeutics Market by Value (2017-2021)
Asia Pacific RNAi Therapeutics Market Forecast by Value (2022-2026)
RoW RNAi Therapeutics Market by Value (2017-2021)
RoW RNAi Therapeutics Market Forecast by Value (2022-2026)
Oncology Pharmaceuticals Market in the U.S. and China (2020-2030)
Global Growth Rate of Infectious Diseases Forecast (2017-2022)
Global Population 65 Years and Above (2017-2021)
Worldwide Projections of Alzheimer’s Disease Prevalence (2015-2040)
Global Personalized Medicine Market (2018-2022)
Market Size of Hypertrophic Scars (HTS) & Keloids Treatments (2020-2030)
Global Molecular Diagnostics Market (2021-2026)
Sanofi S.A. Net Sales and Net Income (2017-2021)
Sanofi S.A. Net Sales by Segment (2021)
Sanofi S.A. Net Sales by Region (2021)
Alnylam Pharmaceuticals Inc. Revenue and Net Loss (2017-2021)
Alnylam Pharmaceuticals Inc. Revenue by Product (2021)
Arrowhead Pharmaceuticals Inc. Revenue & Net Income (Loss) (2017-2021)
Arbutus Biopharma Corporation Revenue and Net Loss (2017-2021)
Benitec Biopharma Ltd. Sales and Net Income (2017-2021)

List of Tables

Comparison of RNAi Treatments against Other Treatment Classes
Platform Comparison of RNAi Therapeutics
Deals in RNAi Therapeutics (2019-2021)
Approved RNAi Therapeutics (2018-2020)
Revenue Comparison of Key Players (2021)
Market Capitalization Comparison of Key Players (2022)
R&D Comparison of Key Players (2021)

  • Global Targeted RNA Sequencing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......
  • Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
  • Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94
    According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
  • Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Market Status and Outlook 2023-2028
    Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106
    RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs